HomeNewsNews Display
News | May 28, 2021

DOD & HHS Announce DPA Title III Agreement with Retractable Technologies, Inc. to Expand Domestic Production Capacity for Low Dead-Space Safety Syringes and Needles

As part of the national response to COVID-19, the Department of Defense (DoD), in coordination with the Department of Health and Human Services (HHS), signed an agreement with Retractable Technologies, Inc. to expand the production of low dead-space (LDS) safety syringes and needles. Government funding allocated was $27.3 million. LDS syringes maximize dose efficiency and allow for additional vaccinations to be obtained from vials. Additional information on the agreement may be found here.